Baidu
map

BMJ子刊:降钙素原可用作发热性中性粒细胞减少症(FN)患者的抗生素停用指标吗?

2022-03-23 网络 网络

发热性中性粒细胞减少症(FN)是儿童和年轻人癌症治疗的常见并发症,许多患者发作的原因是抗生素过度治疗。降钙素原可能是一个预测指标,以指导那些低风险严重细菌感染患者停用抗生素。在这一人群中进行支持性护理

发热性中性粒细胞减少症(FN)是儿童和年轻人癌症治疗的常见并发症,许多患者发作的原因是抗生素过度治疗。降钙素原可能是一个预测指标,以指导那些低风险严重细菌感染患者停用抗生素。在这一人群中进行支持性护理试验已被证明是困难的。这项单臂初步研究(PAnTher Cub)旨在评估在儿童FN患者中用降钙素原(PCT)来判断抗生素停用的可行性。

在FN发作期间进行每日降钙素原水平检测,并给出明确的抗生素停用指导。分析是描述性的。

在32名患者及其家属中,28名患者同意,13名患者出现发热性中性粒细胞减少症。该研究共纳入了16个病例。所有相关的FN发作均已采集数据,并收集足够的数据。没有发生重大安全事件。在4/8(50%)没有明确的微生物记录或临床感染的病例中,抗生素的持续时间或范围都有所缩短对专业人士的采访揭示了研究的重要性、研究团队中关键个人的价值、该方案的特殊挑战以及研究改进建议。

个体患者的连续PCT测量

作为一项单臂试点研究,PAnTherCub是评估PCT指导的FN管理在儿科血液学/肿瘤学中的使用的第一步。下一阶段的研究将包括可行性研究,探索与多个研究地点、患者随机化(到对照组)相关的问题,并确定确定研究所需的样本量。最后阶段将是一个更大的随机对照试验,以评估降钙素原引导方法的使用。

PAnTherCub已经证明,评估PCT指导的儿科FN方法的研究是可能的,并受到儿科血液学/肿瘤学界的欢迎。没有关于安全事件的报道。已经提供了与实施相关的初步结果数据和定性数据,以进一步促进未来的研究设计

参考文献:Morgan JE, Phillips B PAnTher Cub: procalcitonin-guided antibiotic therapy for febrile neutropenia in children and young people with cancer - a single-arm pilot study BMJ Paediatrics Open 2022;6:e001339. doi: 10.1136/bmjpo-2021-001339

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2003885, encodeId=b5d720038851f, content=<a href='/topic/show?id=3f43e621302' target=_blank style='color:#2F92EE;'>#粒细胞减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76213, encryptionId=3f43e621302, topicName=粒细胞减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Mon Jul 11 07:04:32 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849389, encodeId=e809184938930, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Jan 05 08:04:32 CST 2023, time=2023-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981865, encodeId=1d8a198186535, content=<a href='/topic/show?id=311822199b6' target=_blank style='color:#2F92EE;'>#中性粒细胞减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22199, encryptionId=311822199b6, topicName=中性粒细胞减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Aug 25 04:04:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277907, encodeId=af2212e790752, content=<a href='/topic/show?id=464c98221e9' target=_blank style='color:#2F92EE;'>#降钙素原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98221, encryptionId=464c98221e9, topicName=降钙素原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Tue Mar 22 08:04:32 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296785, encodeId=6cc01296e856c, content=<a href='/topic/show?id=29c82219e47' target=_blank style='color:#2F92EE;'>#中性粒细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22197, encryptionId=29c82219e47, topicName=中性粒细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Tue Mar 22 08:04:32 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2003885, encodeId=b5d720038851f, content=<a href='/topic/show?id=3f43e621302' target=_blank style='color:#2F92EE;'>#粒细胞减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76213, encryptionId=3f43e621302, topicName=粒细胞减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Mon Jul 11 07:04:32 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849389, encodeId=e809184938930, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Jan 05 08:04:32 CST 2023, time=2023-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981865, encodeId=1d8a198186535, content=<a href='/topic/show?id=311822199b6' target=_blank style='color:#2F92EE;'>#中性粒细胞减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22199, encryptionId=311822199b6, topicName=中性粒细胞减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Aug 25 04:04:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277907, encodeId=af2212e790752, content=<a href='/topic/show?id=464c98221e9' target=_blank style='color:#2F92EE;'>#降钙素原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98221, encryptionId=464c98221e9, topicName=降钙素原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Tue Mar 22 08:04:32 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296785, encodeId=6cc01296e856c, content=<a href='/topic/show?id=29c82219e47' target=_blank style='color:#2F92EE;'>#中性粒细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22197, encryptionId=29c82219e47, topicName=中性粒细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Tue Mar 22 08:04:32 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
    2023-01-05 gaoxiaoe
  3. [GetPortalCommentsPageByObjectIdResponse(id=2003885, encodeId=b5d720038851f, content=<a href='/topic/show?id=3f43e621302' target=_blank style='color:#2F92EE;'>#粒细胞减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76213, encryptionId=3f43e621302, topicName=粒细胞减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Mon Jul 11 07:04:32 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849389, encodeId=e809184938930, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Jan 05 08:04:32 CST 2023, time=2023-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981865, encodeId=1d8a198186535, content=<a href='/topic/show?id=311822199b6' target=_blank style='color:#2F92EE;'>#中性粒细胞减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22199, encryptionId=311822199b6, topicName=中性粒细胞减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Aug 25 04:04:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277907, encodeId=af2212e790752, content=<a href='/topic/show?id=464c98221e9' target=_blank style='color:#2F92EE;'>#降钙素原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98221, encryptionId=464c98221e9, topicName=降钙素原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Tue Mar 22 08:04:32 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296785, encodeId=6cc01296e856c, content=<a href='/topic/show?id=29c82219e47' target=_blank style='color:#2F92EE;'>#中性粒细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22197, encryptionId=29c82219e47, topicName=中性粒细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Tue Mar 22 08:04:32 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2003885, encodeId=b5d720038851f, content=<a href='/topic/show?id=3f43e621302' target=_blank style='color:#2F92EE;'>#粒细胞减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76213, encryptionId=3f43e621302, topicName=粒细胞减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Mon Jul 11 07:04:32 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849389, encodeId=e809184938930, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Jan 05 08:04:32 CST 2023, time=2023-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981865, encodeId=1d8a198186535, content=<a href='/topic/show?id=311822199b6' target=_blank style='color:#2F92EE;'>#中性粒细胞减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22199, encryptionId=311822199b6, topicName=中性粒细胞减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Aug 25 04:04:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277907, encodeId=af2212e790752, content=<a href='/topic/show?id=464c98221e9' target=_blank style='color:#2F92EE;'>#降钙素原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98221, encryptionId=464c98221e9, topicName=降钙素原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Tue Mar 22 08:04:32 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296785, encodeId=6cc01296e856c, content=<a href='/topic/show?id=29c82219e47' target=_blank style='color:#2F92EE;'>#中性粒细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22197, encryptionId=29c82219e47, topicName=中性粒细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Tue Mar 22 08:04:32 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2003885, encodeId=b5d720038851f, content=<a href='/topic/show?id=3f43e621302' target=_blank style='color:#2F92EE;'>#粒细胞减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76213, encryptionId=3f43e621302, topicName=粒细胞减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Mon Jul 11 07:04:32 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849389, encodeId=e809184938930, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Jan 05 08:04:32 CST 2023, time=2023-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1981865, encodeId=1d8a198186535, content=<a href='/topic/show?id=311822199b6' target=_blank style='color:#2F92EE;'>#中性粒细胞减少#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22199, encryptionId=311822199b6, topicName=中性粒细胞减少)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Aug 25 04:04:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277907, encodeId=af2212e790752, content=<a href='/topic/show?id=464c98221e9' target=_blank style='color:#2F92EE;'>#降钙素原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98221, encryptionId=464c98221e9, topicName=降钙素原)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d521144, createdName=wrj0121, createdTime=Tue Mar 22 08:04:32 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296785, encodeId=6cc01296e856c, content=<a href='/topic/show?id=29c82219e47' target=_blank style='color:#2F92EE;'>#中性粒细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22197, encryptionId=29c82219e47, topicName=中性粒细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3883266, createdName=yykkxiaodou, createdTime=Tue Mar 22 08:04:32 CST 2022, time=2022-03-22, status=1, ipAttribution=)]

相关资讯

降钙素原阳性率低?你需要了解这些!

降钙素原检测在临床中的应用非常普遍,尤其是对于感染的患者,基本上是必开的一项检查。

Clinica Chimica Acta:降钙素原作为危重癌症患者血流感染的预测因子和支持性治疗需求的应用

本研究评估了降钙素原(PCT)在预测有无中性粒细胞减少症的危重癌症患者细菌血流感染(BSI)中的诊断价值。

CLIN CHEM LAB MED:降钙素原在区分隐源性组织肺炎和社区获得性肺炎中的应用

本研究旨在探讨炎症性生物标志物如白细胞(WBC)计数、c -反应蛋白(CRP)和降钙素原(PCT)在区分隐源性组织肺炎(COP)和社区获得性肺炎(CAP)中的作用。

JCEM:降钙素原作为甲状腺髓样癌可替代的肿瘤标志物

在MTC管理中ProCT具有取代降钙素的潜力。

Am J Respir Crit Care Med:降钙素原可降低败血症长期感染相关不良事件的发生风险

虽然在降钙素原(PCT)指导下的早期抗菌素停药已显示出在下呼吸道感染中抗生素的消耗减少,但是长期脓毒症后遗症的结果仍不清楚。为了研究PCT指导是否可以降低脓毒症长期感染相关不良事件的发生率,研究人员进

一例早产儿降钙素原升高原因分析

降钙素原(Procalcitonin,PCT)是机体在全身炎症反应,尤其是细菌感染时释放的一种急性可溶性蛋白,是严重细菌感染和脓毒症的早期诊断标志物。

Baidu
map
Baidu
map
Baidu
map